Inhibikase Therapeutics, Inc. - stock earnings
IKT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.6 million USD | 79569 USD |
| 2023Q2 | -5.8 million USD | 116410 USD |
| 2023Q1 | -4.0 million USD | 64521 USD |
| 2022Q4 | -4.2 million USD | 123440 USD |
| 2022Q3 | -4.5 million USD | 7291 USD |
| 2022Q2 | -4.6 million USD | 6552 USD |
| 2022Q1 | -4.6 million USD | 46031 USD |
| 2021Q4 | -5.0 million USD | 1944 USD |
| 2021Q3 | -4.5 million USD | 328459 USD |
| 2021Q2 | -2.6 million USD | 1.4 million USD |
| 2021Q1 | -2.6 million USD | 1.4 million USD |
| 2020Q4 | -1.2 million USD | 698468 USD |
| 2020Q3 | -670599 USD | 37680 USD |
| 2020Q2 | -421869 USD | 219585 USD |
| 2020Q1 | -547440 USD | 270787 USD |
| 2019Q4 | -430010 USD | 240276 USD |
| 2019Q3 | -1.2 million USD | 124431 USD |
| 2019Q2 | -2.3 million USD | 166931 USD |
| 2019Q1 | -1.7 million USD | 591102 USD |
IKT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -19.1 million USD | ? USD |
| 2022 | -17.9 million USD | 123440 USD |
| 2021 | -14.8 million USD | 3.1 million USD |
| 2020 | -2.9 million USD | 698468 USD |
| 2019 | -5.7 million USD | 1.1 million USD |
| 2018 | -2.2 million USD | 4.0 million USD |
| 2017 | -436075 USD | 2.1 million USD |
IKT
Price: $1.39
52 week price:
Earnings Per Share: -3.57 USD
P/E Ratio: -0.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 146895
Market Capitalization: 9.0 million